Robeco Institutional Asset Management B.V. Ani Pharmaceuticals Inc Transaction History

Robeco Institutional Asset Management B.V.

  • $49.7 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$48.72 - $65.43 $158,534 - $212,909
3,254 New
3,254 $179,000
Q4 2023

Feb 08, 2024
SELL
$48.72 - $65.43 $158,534 - $212,909
-3,254 Closed
0 $3.25 Million
Q3 2023

Oct 23, 2023
BUY
$50.28 - $64.61 $163,611 - $210,240
3,254 New
3,254 $188,000
Q4 2019

Feb 06, 2020
SELL
$55.65 - $79.83 $70,341 - $100,905
-1,264 Closed
0 $0
Q3 2019

Oct 17, 2019
BUY
$64.7 - $85.39 $81,780 - $107,932
1,264 New
1,264 $92,000

Others Institutions Holding ANIP

# of Institutions
212
Shares Held
18.8M
Call Options Held
11.7K
Put Options Held
10.5K
View Full List

About ANI PHARMACEUTICALS INC

ANIP Quotes by TradingView
  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $973M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Robeco Institutional Asset Management B.V. Portfolio

Follow Robeco Institutional Asset Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email